positive
Recently
NephroPlus gets SEBI nod for ₹353 crore IPO to expand global dialysis network
Dialysis provider NephroPlus secures SEBI approval for a ₹353 crore IPO, aiming to expand its clinic network globally and strengthen financials.
NephroCare Health Services (operating as NephroPlus) has secured approval from the Securities and Exchange Board of India (SEBI) for its initial public offering (IPO), comprising a fresh issue of ₹353.4 crore and an offer-for-sale of 1.27 crore shares. The company operates over 500 dialysis centres across India and internationally, including the Philippines, Uzbekistan, and Nepal.
Proceeds will be used to fund expansion, repay debt, and meet general corporate purposes.